Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Submitted by
admin
on October 4, 2012 - 10:50am
Source:
Bloomberg
News Tags:
Sanofi
Lyxumia
diabetes
Bristol-Myers Squibb
Headline:
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Do Not Allow Advertisers to Use My Personal information
